Biolimus A9™ (BA9™) Drug Coated Balloon (DCB) Study

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It enrolled 201 participants.

Also called NCT04079192

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 201 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT04079192
Other papers using this trial's data
  • Final 2-Year Results of the REFORM Study: A Randomized Trial of Biolimus DCB Versus Paclitaxel DCB for In-Stent Restenosis Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2026-10 DOI, PubMed 42605897, PMC13667306 In the PMC Open Access subset under CC BY-NC-ND.
  • Randomized Trial of Biolimus DCB for In-Stent Restenosis: The Primary Results of the REFORM Study JACC. Cardiovascular interventions, 2025-03-10 DOI, PubMed 39918494

Courtesy of the U.S. National Library of Medicine.

Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Germany, Ireland, Italy, Spain, United Kingdom (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT04079192. Randomized; single masking; primary purpose treatment. Start 2020-08-07 (actual); primary completion 2023-04 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Biolimus A9™ (BA9™) Drug Coated Balloon (DCB) Study
Acronym
REFORM
Condition
In-Stent Restenosis
Intervention (Device)
Biolimus A9 Drug Coated Balloon
Intervention (Device)
SeQuent Please Paclitaxel Drug Coated Balloon
Lead sponsor
Biosensors Europe SA (class: industry)

Record details

Record id
cardio:ct-nct04079192
Content hash
58799a37facb2a4cbcb86ea315266597e90acc703396e9c568021cbd9b8507e1